Lipidomic Signatures Informs Intravenous Racemic Ketamine Associated Remission in Treatment-Resistant Depression: A Pilot Study

被引：0
|
作者：
Singh, Balwinder [1 ]
MahmoudianDehkordi, Siamak [1 ]
Voort, Jennifer Vande [1 ]
Han, Xianlin [1 ]
Port, John [1 ]
Frye, Mark [1 ]
Daouk, Rima Kaddurah [1 ]
机构：
[1] Mayo Clin, Coll Med, Rochester, MN USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2022年 / 47卷
关键词：
IV; Ketamine; Metabolomics Signature; Treatment; Resistant Depression; Open Label Trials;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P227
引用
收藏
页码：192 / 192
页数：1
相关论文
共 50 条
  • [31] Intranasal Ketamine in Treatment-resistant Depression
    Lapidus, Kyle A.
    Levitch, Cara F.
    Soleimani, Laili
    Perez, Andrew M.
    Brallier, Jess W.
    Parides, Michael K.
    Iosifescu, Dan V.
    Charney, Dennis S.
    Murrough, James W.
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S361 - S361
  • [32] Oral ketamine for treatment-resistant depression
    Kang, Seema
    LANCET PSYCHIATRY, 2018, 5 (11): : 877 - 877
  • [33] Esketamine/ketamine for treatment-resistant depression
    Lacerda, Acioly L. T.
    BRAZILIAN JOURNAL OF PSYCHIATRY, 2020, 42 (06) : 579 - 580
  • [34] A Case of Sustained Remission Following an Acute Course of Ketamine in Treatment-Resistant Depression
    Murrough, James W.
    Perez, Andrew M.
    Mathew, Sanjay J.
    Charney, Dennis S.
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (03) : 414 - 415
  • [35] KETAMINE FOR ADOLESCENT TREATMENT-RESISTANT DEPRESSION
    Cullen, Kathryn R.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (10): : S345 - S345
  • [36] SUBLINGUAL KETAMINE FOR TREATMENT-RESISTANT DEPRESSION
    Hyde, S.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2017, 51 : 154 - 154
  • [37] Propofol for Treatment-Resistant Depression: A Pilot Study
    Mickey, Brian J.
    White, Andrea T.
    Arp, Anna M.
    Leonardi, Kolby
    Torres, Marina M.
    Larson, Adam L.
    Odell, David H.
    Whittingham, Sara A.
    Beck, Michael M.
    Jessop, Jacob E.
    Sakata, Derek J.
    Bushnell, Lowry A.
    Pierson, Matthew D.
    Solzbacher, Daniela
    Kendrick, E. Jeremy
    Weeks, Howard R., III
    Light, Alan R.
    Light, Kathleen C.
    Tadler, Scott C.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2018, 21 (12): : 1079 - 1089
  • [38] Intravenous Ketamine for Late-Life Treatment-Resistant Depression: A Pilot Study of Tolerability, Safety, Clinical Benefits, and Effect on Cognition
    Oughli, Hanadi Ajam
    Gebara, Marie Anne
    Ciarleglio, Adam
    Lavretsky, Helen
    Brown, Patrick J.
    Flint, Alastair J.
    Farber, Nuri B.
    Karp, Jordan F.
    Mulsant, Benoit H.
    Reynolds, Charles F., III
    Roose, Steven P.
    Yang, Lei
    Butters, Meryl A.
    Lenze, Eric J.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2023, 31 (03): : 210 - 221
  • [39] Effect of intravenous ketamine on suicidality in adults with treatment-resistant depression: A real world effectiveness study
    Chen-Li, David C. J.
    Mansur, Rodrigo B.
    Di Vincenzo, Joshua D.
    Chisamore, Noah
    Kaczmarek, Erica
    Mcintyre, Roger S.
    Rosenblat, Joshua D.
    PSYCHIATRY RESEARCH, 2025, 343
  • [40] The Association Between Body Mass Index and Remission Rates in Patients With Treatment-Resistant Depression Who Received Intravenous Ketamine
    Singh, Balwinder
    Bobo, William V.
    Rasmussen, Keith G.
    Stoppel, Cynthia J.
    Rico, Jose A., Jr.
    Schak, Kathryn M.
    Biernacka, Joanna M.
    Frye, Mark A.
    Vande Voort, Jennifer L.
    JOURNAL OF CLINICAL PSYCHIATRY, 2019, 80 (06)
12345